Atara Biotherapeutics Presents Tab-cel Clinical Biomarker Results and Nasopharyngeal Carcinoma Study Design at American Society of Clinical Oncology (ASCO) Annual Meeting Nasdaq:ATRA

Press/Media: Press / Media

PeriodJun 1 2019

Media coverage

1

Media coverage

  • TitleAtara Biotherapeutics Presents Tab-cel Clinical Biomarker Results and Nasopharyngeal Carcinoma Study Design at American Society of Clinical Oncology (ASCO) Annual Meeting Nasdaq:ATRA
    Media name/outletGlobal English (Middle East and North Africa Financial Network)
    CountryJordan
    Date6/1/19
    PersonsMissak Haigentz